Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
More than 90% of people in the world own or use a mobile phone, and many of us couldn't live without them. We carry them everywhere we go, use them in bed and the bathroom, and for many people, they are the first thing they see in the morning.
Read Full NewsIZAR-1: Sonelokimab Meets Phase 3 End Points for PsA
Two-season real-world data show Arexvy reduces RSV-related MACE and COPD and asthma exacerbations in adults 60 and older, Ann Falsey, MD, says.
Guy Brusselle, MD, PhD, says that 64% of dupilumab-treated patients met composite asthma clinical remission criteria at week 24 versus 40.5% with omalizumab.
What The FDA Psychedelic Hearing Means for Psychiatrists
A new phase 4 trial, OCTAGON, will test a rapid, predefined corticosteroid-tapering schedule in patients with generalized myasthenia gravis treated with ravulizumab.
A phase 4 study is evaluating whether adults with chronic inflammatory demyelinating polyneuropathy can transition from intravenous immunoglobulin to subcutaneous efgartigimod PH20 without first experiencing disease worsening.
Real-world 12‑month results from WeSMA, a phase 4 study, showed that oral risdiplam is well tolerated in adults with SMA, with stable motor function and consistent safety findings.
1.
Obesity-associated cancers tripled nationwide over past two decades
2.
According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.
3.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
4.
MGRS Relapse-Free Survival Better With Maintenance Therapy
5.
Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth
1.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
2.
Practical Applications in Hematology Across Clinical Settings
3.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
4.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
5.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
3.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
5.
Best Practices in Hematology
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge